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 ■  PURPOSE:  The primary aims of this study were (1) to evaluate whole-body 
mechanical efficiency (ME) in a large group of chronic obstructive pul-
monary disease (COPD) patients with a wide range of degrees of ill-
ness and (2) to examine how ME in COPD is related to absolute work 
rate and indices of disease severity during exercise testing. 
 ■  METHODS:  A total of 569 patients (301 male patients; GOLD stage I: 28, 
GOLD stage II: 166, GOLD stage III: 265, and GOLD stage IV: 110) 
with chronic obstructive pulmonary disease (COPD) were included in 
the data analysis. Individual maximal workload (watt), peak minute 
ventilation ( V ·  E , L/min body temperature and pressure, saturated), and 
peak oxygen uptake ( V ·  O 2  , mL/min standard temperature and pressure, 
dry) were determined from a maximal incremental cycle ergometer 
test. Ventilatory and metabolic response parameters were collected 
during a constant work rate test at 75% of the individual maximal 
workload. From the exercise responses of the constant work rate test, 
the gross ME was calculated. 
 ■  RESULTS:  The mean whole-body gross ME was 11.0  ± 3.5% at 75% peak 
power. The ME declined significantly ( P  < .001) with increasing sever-
ity of the disease when measured at the same relative power. Log-
transformed absolute work rate ( r  = .87,  P  < .001) was the strongest 
independent predictor of gross ME. Body mass was the single other 
variable that contributed significantly to the linear regression model. 
 ■  CONCLUSIONS:  Gross ME in COPD was largely predicted by the absolute 
work rate ( r  = .87;  P  < .001) while indices of the severity of the dis-
ease did not predict ME in COPD. 
 Mechanical Efficiency in Chronic 
Obstructive Pulmonary Disease 
 Willem  Gosens ,  MSc ;  Alex J.  van’t Hul ,  PhD ;  Joost M.  Oomen ,  PhD ;  Matthijs K. C.  Hesselink ,  PhD ;  
 Lars B.  Borghouts ,  PhD 
 Chronic obstructive pulmonary disease (COPD) is 
clinically characterized by an exertional dyspnea, 
fatigue, and exercise intolerance. As a consequence, 
patients with COPD have a reduced ability to per-
form activities of daily life 1 and experience impaired 
quality of life. 2 The underlying mechanisms of symp-
toms and exercise intolerance are complex, may 
vary from patient to patient, and are still a topic of 
debate. 3 Several of these mechanisms may poten-
tially result in an increase in the metabolic demand 
per unit of external mechanical work, and as a con-
sequence, negatively affect the mechanical efficiency 
(ME) for whole-body exercise. 4 Mechanical efficien-
cy of an activity is defined as the ratio of external 
work relative to energy expenditure. 4 A diminished 
ME has been suggested to exacerbate the clinical 
impact of COPD and may result in exercise intoler-
ance. 5 These findings have been interpreted to sug-
gest particular strategies for rehabilitation. 5 , 6 Only a 
few studies, however, have evaluated ME in patients 
with COPD and reported conflicting results. Perrault 
et al 7 found no difference in ME during cycling 
ergometry between patients with moderate to severe 
COPD and age-matched healthy controls, despite 
 DOI:  10.1097/HCR.0000000000000241
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elevated ventilation and dynamic hyperinflation in 
COPD. By contrast, others have suggested a reduced 
net ME in patients with COPD when compared with 
reference values of healthy subjects. 6 , 8 , 9 However, as 
COPD is characterized by exercise intolerance, 
patients are limited to modest absolute work rates 
during exercise testing. Ettema et al 10 showed that 
absolute work rate explains approximately 90% of 
the gross ME in healthy subjects. 10 The low absolute 
work rates used in previous studies investigating ME 
in COPD might therefore have confounded the 
observation of impaired ME in these patients. Thus, 
we hypothesized that absolute work rate is the major 
determinant of gross ME during cycle ergometry in 
patients with COPD. 
 Determining the mechanisms responsible for 
exercise intolerance in COPD is of utmost impor-
tance to design optimal rehabilitation programs. 
Therefore, the primary aims of this study were (1) 
to evaluate whole-body ME in a large group of 
COPD patients with a wide range of degrees of ill-
ness and (2) to examine how ME in COPD is related 
to absolute work rate and indices of disease severity 
during exercise testing. 
 METHODS 
 Patients with COPD categorized according to the 
criteria set by the Global Initiative for Obstructive 
Lung Disease scientific committee 11 who were 
referred for pulmonary rehabilitation at Revant 
Rehabilitation Center in Breda, The Netherlands, 
were studied. The institutional ethical review board 
approved this study. 
 Post–bronchodilator forced expired ventilation in 
1 second (FEV 1 ) was used to classify the patients into 
the appropriate GOLD stage. 11 Patients included with 
COPD (GOLD stages I-IV) were clinically stable. 
Patients had stopped smoking, were at least 40 years 
old, and had no evidence of cardiac disease at the 
time of the assessments. Exclusion criteria for this 
study were comorbidities that could influence the test 
results (ie, skeletal muscle problems) and the pres-
ence of exacerbations in the 8 weeks preceding meas-
urements. Furthermore, all patients requiring supple-
mental oxygen were excluded because no metabolic 
measurements could be performed in the laboratory. 
Patients with a constant work rate performance 
 < 4 minutes during the constant work rate test (CWRT) 
were excluded from the test because measurement of 
oxygen uptake may be underestimated in these 
patients. Data were collected over a 4-year period 
(2007-2010). 
 Pulmonary Function 
 Pulmonary function measurements (spirometry, static 
lung volumes, and carbon monoxide transfer factor) 
were collected using automated equipment (MS-PFT and 
MS-Body, Viasys Healthcare, Höchberg, Germany) and 
according to recommended standards. 12 Measurements 
were related to reference values from Quanjer et al. 13 
 Body Mass and Body Mass Index 
 Body mass was determined using a mechanical 
weight scale (model 761, Seca, Hamburg, Germany). 
Patients wore only underwear during the weighing. 
Height was measured using a wall-mounted stadiom-
eter with individuals standing barefoot. Body mass 
index was calculated dividing body mass by squared 
height (kg/m 2 ). 
 Six-Minute Walk Distance 
 The 6-minute walk distance was evaluated in a gym-
nasium with a square track of 5 by 10 m. Patients 
were instructed to walk as many meters as possible in 
6 minutes and were allowed to stop and rest during 
the test, if necessary. During the test, patients were 
encouraged in a standardized manner. 14 
 Maximal Incremental Exercise Test 
 A symptom-limited exercise test was performed accord-
ing to the American Thoracic Society/American College 
of Chest Physicians recommendations 15 on an electro-
magnetically braked cycle ergometer (Ergoselect 1000 LP/
1000 LK, Ergoline, Bitz, Germany) to determine maximal 
power output. Peak minute ventilation ( V·  E , L/min body 
temperature and pressure, saturated) and peak pulmo-
nary oxygen uptake ( V·  O 2  , mL/min standard temperature 
and pressure, dry) were measured with a breath-by-
breath automated exercise metabolic system (Oxycon 
Pro/Delta, Viasys Healthcare, Wuerzburg, Germany). 
Maximal workload in watts (W max ) and peak  V
·  O 2  were 
compared with the reference values from Jones et al. 16 
Prior to the start of the test, spirometry was performed to 
be able to estimate peak  V·  E . 17 
 Constant Work Rate Test 
 The CWRT measurements were part of usual care at the 
rehabilitation center. Exercise endurance to a symptom-
limited maximum was determined with a constant work 
rate exercise test on an electromagnetically braked 
cycle ergometer (Ergoselect 1000 LP/1000 LK Ergoline, 
Bitz, D-72475, Germany) at a work rate equal to 75% of 
the peak work rate attained in the earlier incremental 
test. Reliability and validity of this test have been shown 
to be good. 18 , 19 During testing, ventilatory and meta-
bolic response parameters were collected with the 
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same metabolic cart as in the incremental exercise test 
(Oxycon Pro/Delta, Viasys Healthcare, Höchberg, 
Germany). Ventilatory responses included the measure-
ment of inspiratory capacity (IC) at rest and at 2-minute 
intervals. To perform the IC maneuver, patients were 
instructed to make a maximal inspiration maneuver, 
after the end of a normal breath. 20 The maneuver 
ended with a normal, unforced expiration. The mean 
values of the last 20 seconds of metabolic and ventila-
tory variables of the CWRT were used for analysis to 
calculate the gross efficiency (GE). 
 Calculation of Gross ME 
 Mechanical efficiency is defined by the ratio of the 
external mechanical work in watts (W) to the meta-
bolic energy expenditure expressed in joules per 
second (J/s): GE (%)  = work rate [W]/energy expended 
[J/s]  × 100% for an activity. According to Ettema et al, 10 
gross ME is the most robust expression of ME. Gross 
efficiency is expressed as the percentage ratio of exter-
nal work performed to the total energy expenditure 
during the cycle ergometry exercise. For the assessment 
of gross ME, metabolic and ventilatory variables were 
measured breath by breath during the CWRT per-
formed at 75% of the maximal incremental exercise test 
by using a breathing mask. The abbreviated Weir equa-
tion was used to calculate the total energy expenditure 
during exercise from values of  V·  O 2  and carbon dioxide 
production ( V·  cO 2  ); EE  = [3.9 ( V
·  O 2  mL/min)  + 1.1 ( V
·  cO 2  
mL/min)] (kcal/min). 21 , 22 Both total energy expenditure 
and external work were recalculated into kJ/min to 
allow the calculation of percent ME. 
 Statistical Analysis 
 Continuous data are presented as mean  ± standard 
deviation.  P  < .05 was considered statistically signifi-
cant. The mean gross ME was calculated for the 
population as a whole and for each GOLD stage. 
Differences in ME between the GOLD stages were 
assessed by means of 1-way analysis of variance. A 
Bonferroni  post hoc test was used when appropriate, 
to evaluate differences between variables within 
groups. The maximum watts (W max ) data were not 
normally distributed; therefore, logarithmic transfor-
mation was used to normalize these. The Pearson 
correlation was used to calculate the degree of asso-
ciation between gross ME, patient characteristics, and 
clinical exercise characteristics. Associations  > 0.2 
were used in the linear regression model to assess the 
factors that predict gross ME. Multiple linear regres-
sion models were used with gross ME as the depend-
ent variable, and patient characteristics and clinical 
exercise characteristics as independent variables. To 
compare our data with earlier studies, linear regres-
sion models were fitted with and without inclusion of 
absolute work rate as independent predictors of gross 
ME. SPSS version 19.0 for Windows (IBM, Chicago, IL) 
was used to analyze the data. 
 RESULTS 
 Five hundred sixty-nine patients (301 male) with 
COPD (28 GOLD stage I; 166 GOLD stage II; 265 
GOLD stage III; and 110 GOLD stage IV) were includ-
ed in the data analysis. All patients had a history of 
cigarette smoking but had quit smoking prior to inclu-
sion in the study. Descriptive characteristics of age, 
gender, body mass index, pulmonary function, and 
GOLD stage, as well as clinical exercise data are pro-
vided in  Table 1 . 
 Mechanical Efficiency 
 The mean whole-body gross ME was 11.0  ± 3.5%. 
The gross ME declined significantly ( P  < .001) with 
increasing severity of the disease compared at the 
same  relative workload as shown in  Figure 1 . There 
was a significant difference for ME between all GOLD 
stages, except between GOLD stages I and II. 
 Independent Predictors of Gross ME 
 FEV 1 ( R 
2  = 0.55;  P  < .001) was found to be the 
strongest independent predictor of gross ME when 
absolute work rate was excluded from the linear 
regression model explaining 31% of the variation 
( R 2  = 0.31;  P  < .001) in gross ME. Other variables 
that contributed to the linear regression model, as 
reflected by  Δ R 2 , were diffusing capacity of carbon 
monoxide and body mass ( Table 2 ), while arterial 
oxygen tension at rest, residual volume, total lung 
capacity, and IC rest each contributed  < 0.02 to  Δ R 2 . 
When absolute work rate was included in the regres-
sion model, it was the strongest independent predic-
tor of gross ME ( R 2  = 0.87;  P  < .001). In that case, 
body mass was the only patient characteristic that 
contributed significantly to the linear regression 
model ( Table 3 ). 
 DISCUSSION 
 This large-scale study demonstrated that, when 
patients are compared at the same  relative workload, 
gross ME seemingly declines with increasing severity 
of disease in COPD. However, when gross ME is 
expressed as a function of  absolute work rate, there is 
no relation between gross ME and indices of disease 
severity. Previous reports of a decreased ME in COPD 
in comparison to values in healthy controls should be 
interpreted in the light of these findings. 
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 It has been proposed that ME in COPD is 
decreased, caused by an increased energy demand of 
breathing. 6 , 23 , 24 If the additional ventilatory work 
required to overcome the increased airway resistance 
in COPD would significantly increase oxygen utiliza-
tion of the respiratory muscles during exercise, and 
thereby metabolic rate, 25 ME would decline with 
increasing airway resistance. Another theoretical cause 
of impaired ME in COPD is the bioenergetic abnormalities 
found in skeletal muscle, such as muscle fiber type 
shifting from type I to II. 26 It has been suggested that 
the quadriceps femoris muscle in COPD patients is 
particularly affected, 27-29 thus impacting cycling and 
walking activities and possibly ME. 30 
 We were able to identify a very limited number of 
previous, relatively small-scale studies evaluating ME 
in patients with COPD, which had significantly 
divergent conclusions. Perrault et al 7 concluded that 
 T a b l e  1 •  Patient Demographic and Clinical Characteristics 
 
GOLD I 
(n  = 28) 
GOLD II 
(n  = 166) 
GOLD III 
(n = 265) 
GOLD IV 
(n  = 110) 
Total 
(N  = 569) 
Gender, male/female 14/14 73/93 144/121 70/40 301/268 
Age, y 64  ± 10 63  ± 10 a 63  ± 10 b 60  ± 9 63  ± 9 
BMI, kg/m 2 30.4  ± 6.3 c,d 28.4  ± 5.8 a,e 25.8  ± 5.2 24.4  ± 5.1 26.5  ± 5.7 
FEV 1, L 2.31  ± 0.70 c,d,f 1.61  ± 0.46 a,e 1.05  ± 0.26 b 0.75  ± 0.17 1.22  ± 0.53 
FEV 1, % pred 87  ± 5 61  ± 8 39  ± 6 26  ± 5 45  ± 17 
SVC, L 4.06  ± 1.22 c,d,f 3.52  ± 0.95 3.42  ± 0.89 3.21  ± 0.71 3.44  ± 0.91 
SVC, % pred 118  ± 16 106  ± 18 99  ± 15 86  ± 13 99  ± 18 
FEV 1 /VC, % 58  ± 9 c,d,f 46  ± 9  a,e 32  ± 6 b 24  ± 5 36  ± 11 
TLC, L 6.68  ± 1.65 d 6.37  ± 1.21 a,e 7.16  ± 1.36 b 7.89  ± 1.47 7.05  ± 1.46 
TLC, % pred 113  ± 15 112  ± 17 122  ± 17 128  ± 19 120  ± 18 
FRC, L 3.53  ± 1.19 c,d 3.74  ± 0.83 a,e 4.80  ± 1.03 b 5.86  ± 1.34 4.63  ± 1.31 
FRC, % pred 112  ± 31 124  ± 27 151  ± 28 181  ± 35 148  ± 36 
RV, L 2.62  ± 0.78 c,d 2.88  ± 0.59 a,e 3.74  ± 0.80 b 4.69  ± 1.15 3.62  ± 1.05 
RV, % pred 118  ± 27 135  ± 31 171  ± 37 214  ± 51 166  ± 48 
DL CO , mMol/L/s 5.30  ± 1.46 4.74  ± 1.66 4.18  ± 6.09 3.33  ± 1.11 4.25  ± 4.34 
DL CO , % pred 64  ± 14 58  ± 16 46  ± 15 38  ± 12 49  ± 17 
Pa O 2 rest, kPa 9.2  ± 0.9 9.3  ± 0.9 9.0  ± 0.9 8.7  ± 0.9 9.1  ± 0.9 
Pa CO 2 rest, kPa 4.7  ± 0.4 5.0  ± 0.5 5.1  ± 0.6 5.5  ± 0.6 5.1  ± 0.6 
6MWD, m 407  ± 111 421  ± 100 a 406  ± 96 b 360  ± 91 402  ± 99 
6MWD, % pred 66  ± 15 68  ± 14 63  ± 13 53  ± 14 63  ± 15 
W max , watt 82  ± 36 c,d,f 66  ± 35 a,e 48  ± 25 b 33  ± 16 52  ± 30 
W max , % pred 60  ± 19 51  ± 18 35  ± 15 22  ± 10 38  ± 19 
Absolute work rate CWRT, W 61  ± 27 c,d,f 50  ± 26 a,e 36  ± 18 b 24  ± 12 40  ± 23 
Gross ME, % 13.7  ± 3.3 c,d 12.6  ± 3.3 a,e 10.7  ± 3.1 b 8.7  ± 3.0 11.0  ± 3.5 
 Abbreviations: BMI, body mass index; CWRT, constant work rate test; DL CO , diffusing capacity for carbon monoxide; FEV 1 , forced expiratory volume in 
1 second; FRC, functional residual capacity; Gross ME, gross whole-body mechanical efficiency; Pa CO 2 , arterial carbon dioxide tension; Pa O 2 rest, arterial oxy-
gen tension; RV, residual capacity; SVC, slow vital capacity; TLC, total lung capacity; VC, vital capacity; W max , maximal workload; 6MWD, 6-minute walk dis-
tance. 
 P  < .05: 
 a Between GOLD II and GOLD IV. 
 b Between GOLD III and GOLD IV. 
 c Between GOLD I and GOLD III. 
 d Between GOLD I and GOLD IV. 
 e Between GOLD II and GOLD III. 
 f Between GOLD I and GOLD II. 
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ME during ergometry was not compromised in COPD 
but others have suggested a marked reduction. 6 , 9 , 31 , 32 
Since gross ME during cycle ergometry is closely 
related to absolute work rate in healthy subjects, 10 we 
hypothesized that differences in absolute work rate 
between the assessment of ME in COPD and healthy 
subjects might account for the discrepancies previ-
ously reported for ME in COPD and healthy subjects. 
 At a relative workload of 75% W peak , we observed 
a mean gross ME during submaximal cycling of 
11.0  ± 3.5% and a significant decline in gross ME with 
progressing GOLD stages. The difference between 
GOLD stages I and II was nonsignificant, however, 
which could possibly be attributed to a relatively 
small sample in the GOLD stage I group (n  = 28). The 
apparent relation between gross ME and disease 
severity was seemingly confirmed when FEV 1 was 
found to be the main predictor of gross ME in our 
regression model that included only patient character-
istics ( Table 2 ). However, when the absolute work 
rate during cycle ergometry was included to the 
model, this explained 75% of the variation in gross 
ME. Thus, body mass remained as the sole patient 
characteristic adding significantly to the model 
( Table 3 ). Therefore, ME in patients with COPD is 
largely explained by the absolute work rate during 
cycle ergometry at which ME is calculated. This is in 
agreement with data in healthy subjects where abso-
lute work rate explains an even greater proportion 
(approximately 90%) of the variation in efficiency. 10 
This difference in the strength of the relationship 
between gross ME and absolute work rate in patients 
with COPD and healthy subjects may be partially 
attributable to indices of disease severity in COPD, 
but this needs further study. Other likely candidates to 
explain differences in ME between studies are pedal-
ing cadence and techniques, familiarization with the 
exercise, and population characteristics, since these 
are all known to affect ME in humans. 10 , 33 
 In COPD, an increased severity of disease is associ-
ated with decreased exercise tolerance. In our study, 
this was demonstrated by the significant decline in 
 T a b l e  3 •   Regression Models for Gross 
Mechanical Efficiency in COPD 
(Log-Transformed Absolute 
Work Rate Included) 
Dependent Variable: Gross Mechanical Efficiency in COPD 
  R  2  Δ R  2  β 
Model 1 : F change (1, 538)  = 1678.47;  P  < .05 0.75   
 Constant 
 Log-transformed absolute work rate, W   0.87 a 
Model 2 : F change (2, 537)  = 1150.20;  P  < .05 0.81 0.06  
 Constant 
 Log-transformed absolute work rate, W   0.97 a 
 Body mass, kg    − 0.25 a 
 Abbreviations:  β , beta coefficient; COPD, chronic obstructive pulmonary 
disease. 
 a P  < .05. 
 Figure 1.  Mean gross mechanical efficiency calculated at the same 
relative workload (75% peak work rate) and the mean external 
power at which gross ME was calculated for patients in each GOLD 
stage. Abbreviations: GOLD, Global Initiative for Chronic Obstruc-
tive Lung Disease; ME, mechanical efficiency; W, watts. 
 T a b l e  2 •   Regression Models for Gross 
Mechanical Efficiency in COPD 
(Log-Transformed Absolute 
Work Rate Excluded) 
Dependent Variable: Gross Mechanical Efficiency in COPD 
  R  2  Δ R  2  β 
Model 1 : F change (1, 508)  = 222.79;  P  < .05 0.31   
 Constant 
 FEV 1   0.55 a 
Model 2 : F change (2, 507)  = 131.80;  P  < .05 0.34 0.03  
 Constant 
 FEV 1 , L   0.40 a 
 DL CO , mMol/L/s   0.25 a 
Model 3 : F change (3, 506)  = 107.65;  P  < .05 0.39 0.05  
 Constant 
 FEV 1 , L   0.43 a 
 DL CO , mMol/L/s   0.39 a 
 Body mass, kg    − 0.27 a 
 Abbreviations:  β , beta coefficient; COPD, chronic obstructive pulmonary 
disease;  FEV 1 , forced expiratory volume in 1 second; DL CO ,  diffusing 
capacity for carbon monoxide. 
 a P  < .05. 
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peak work rate with increasing severity of disease 
( Figure 1 ). As a consequence, there were significant 
differences in absolute work rates between GOLD 
stages when tested at the same  relative power. During 
cycling, gross ME decreases rapidly at low absolute 
work rates in healthy subjects. When gross ME is 
expressed as a function of  absolute work rate, there is 
no relation between gross ME and indices of disease 
severity ( Table 3 ). The impact of work rate on gross 
ME diminishes strongly above approximately 150 W 
in healthy subjects. 10 Our study suggests that this pat-
tern of gross ME, as a function of external power, is 
similar in COPD ( Figure 2 ). When we plotted our 
results for gross ME as a function of external power 
in COPD against a large set of studies reviewed by 
Ettema and Lorås, 10 negligible differences were found 
between COPD and healthy subjects ( Figure 3 ). We 
therefore assume that gross ME of cycling exercise in 
COPD is approximately equal to gross ME in healthy 
subjects, at least at the low absolute work rates com-
monly applied in COPD. Further studies, directly 
comparing patients and controls, are necessary to 
clarify whether this assumption is correct. 
 Since patients with COPD are uniformly restricted to 
low absolute work rates during submaximal exercise 
caused by their exercise intolerance, the ME in these 
patients will be decreased, by default, when compared 
with ME measured at higher absolute work rates in 
healthy subjects. Previous studies reporting impaired ME 
in COPD 6 , 8 , 9 , 32 might have been confounded by this 
effect. For example, Baarends et al 6 concluded that ME 
in COPD was decreased compared with ME in healthy 
subjects during submaximal cycling exercise. 6 However, 
this conclusion was based upon the comparison of their 
findings in COPD (a net ME of 15.5%) to a reference 
value in healthy subjects derived from another study 
(23%). 8 Although the mean absolute work rate at which 
ME was calculated was not reported, it can be assumed 
that the applied workload of 50% peak work rate in 
severe COPD (GOLD III) was significantly lower than 
that in healthy subjects calculated at the same relative 
workload. In an earlier study, Palange et al 8 did com-
pare ME in COPD directly to a control group. Mechanical 
efficiency was again considered very low (16%) in 
COPD patients compared with healthy subjects (24.5%), 
but the absolute work rate at which ME was assessed 
was twice as high in healthy (50 W) subjects as in COPD 
patients (24 W). Similarly, Franssen et al 33 concluded 
that ME during cycling was decreased in COPD, 
although the absolute work rate at which ME was 
assessed was approximately 3 times higher in healthy 
controls (100 W) than in COPD patients (31 W). In addi-
tion, Franssen et al also concluded that arm ME, in 
contrast to leg ME, was relatively preserved in clinically 
stable COPD. The differences in absolute work rate 
between COPD and healthy controls in the arm exercise 
 Figure 2.  External power plotted against gross mechanical efficiency. 
 R 2  = 0.76 (exponential function);  R  = 0.87. Abbreviations: GOLD, 
Global Initiative for Chronic Obstructive Lung Disease; W, watts. 
 Figure 3.  The figure shows an overview of data from the literature re-
lated to the quantification of efficiency. In this figure, external power 
is plotted against average gross ME in healthy subjects (open circles) 
as reviewed by Ettema et al 10 and depicts a possible measurement 
error of 5%. The thick, black curve is the average curve, based on 
the regression line from the studies included. Thinner curves indicate 
ranges if both metabolic rate and external power have a deviation 
(error) of 5% in either direction. The thick vertical error bar indicates 
the same range if only 1 of the measures had a 5% deviation and the 
horizontal arrows indicate the efficiency difference resulting from 
this error. The solid black circle symbol (•) represents the highest 
power in the study by Luhtanen et al. 29 The larger symbols (■, ♦, ▲, 
✥) represent the mean gross ME in persons with COPD by GOLD 
stages in the present study. Abbreviations: COPD, chronic obstruc-
tive pulmonary disease; GOLD, Global Initiative for Chronic Ob-
structive Lung Disease; ME, mechanical efficiency; W, watts. 
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experiment, however, were much smaller than in the 
leg exercise experiment and might therefore account for 
the assumedly “preserved” arm exercise ME in COPD. 
 In contrast, Perrault et al 7 concluded that cycling 
delta efficiency was not compromised in moderately 
severe COPD compared with healthy controls. In this 
study, delta ME (ie, the change in efficiency between 
different work rates) was calculated between relative 
cycling work rate of 20% versus 65% peak power. 
Again, patients had a significantly lower peak power 
than healthy controls and therefore lower absolute 
work rates at which delta ME was calculated. These 
differences in absolute work rates might have influ-
enced the comparison of delta efficiency between 
COPD and healthy control subjects. Nonetheless, 
Perrault et al 7 found no differences in ( V·  O 2  (L/min) 
between COPD and healthy subjects at rest, during 
unloaded cycling and at the same absolute work rate 
of 20 W, which confirms the findings in this study. 
 For patients with COPD, the ability to perform large 
muscle mass physical activity such as cycling and walk-
ing is critical to activities of daily living. Therefore, our 
findings that there are no greater energy requirements 
in COPD patients during work of intensities comparable 
with activities of daily living may be used to reinforce 
the value of exercise for rehabilitation purposes. 
Furthermore, insight into the underlying mechanisms of 
exercise intolerance in COPD can inform decisions con-
cerning rehabilitation strategies. The presumed attenua-
tion of ME in patients with COPD has been used as an 
argument to emphasize the use of small muscle mass 
exercises, 32 maximal strength training of the legs, 5 and 
lower intensity training programs. 6 Although other 
(patho)physiological findings may possibly support 
these claims for the effectiveness of particular exercise 
programs in COPD patients, our study demonstrated 
that they are not corroborated by an altered ME. 
 In summary, this study demonstrates that when 
gross ME is expressed as a function of  absolute work 
rate, there is no relation between gross ME and indi-
ces of disease severity in COPD. Further study is 
needed to evaluate whether gross ME, calculated at 
the same absolute work rate, is altered in COPD com-
pared with healthy subjects. 
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